Press release
Nonalcoholic Fatty Liver Disease (NAFLD) Market Booming Worldwide With Leading Key Players - Pfizer Inc., AstraZeneca, Novartis AG, Takeda Pharmaceutical Company Limited., Intercept Pharmaceuticals, Inc., F. Hoffmann-La Roche Ag, Merck & Co
Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/nonalcoholic-fatty-liver-disease-market
The Nonalcoholic Fatty Liver Disease (NAFLD) market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.
Nonalcoholic fatty liver disease (NAFLD) refers to a spectrum of liver conditions characterized by excessive fat accumulation in the liver of individuals who consume little to no alcohol. It is often associated with obesity, insulin resistance, metabolic syndrome, and other risk factors such as diabetes and high cholesterol levels. NAFLD can range from simple fatty liver (steatosis), which usually causes no symptoms and does not progress, to nonalcoholic steatohepatitis (NASH), a more severe form characterized by inflammation and liver cell damage. NASH can progress to fibrosis, cirrhosis (severe scarring of the liver), and even liver failure or liver cancer in some cases. Management of NAFLD involves lifestyle modifications such as weight loss, dietary changes, regular exercise, and management of underlying conditions like diabetes and high cholesterol. In more severe cases, medications and close monitoring by healthcare providers are necessary to prevent progression and manage complications.
Forecast Growth Projected:
The Global Nonalcoholic Fatty Liver Disease (NAFLD) Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
List of the Key Players in the Nonalcoholic Fatty Liver Disease (NAFLD) Market:
Pfizer Inc., AstraZeneca, Novartis AG, Takeda Pharmaceutical Company Limited., Intercept Pharmaceuticals, Inc., F. Hoffmann-La Roche Ag, Merck & Co., Inc., Abbvie Inc., And Gilead Sciences, Inc. among others.
Segment Covered in the Nonalcoholic Fatty Liver Disease (NAFLD) Market:
By Drug Class: Antioxidants, Lipid-Lowering Drugs, Insulin sensitizers, Pentoxifylline, Angiotensin Receptor Blockers, Others
By Disease Stage: Non-Alcoholic Steatohepatitis (NASH), Cirrhosis, Fibrosis
By Route of Administration: Injectable, Oral, Other
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
Regional Analysis:
The global Nonalcoholic Fatty Liver Disease (NAFLD) Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
Get Customization in the report as per your requierments: https://datamintelligence.com/customize/nonalcoholic-fatty-liver-disease-market
Regional Analysis:
The global Nonalcoholic Fatty Liver Disease (NAFLD) Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Nonalcoholic Fatty Liver Disease (NAFLD) Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Nonalcoholic Fatty Liver Disease (NAFLD) manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Nonalcoholic Fatty Liver Disease (NAFLD) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Get a Free Sample PDF copy of the report @ https://datamintelligence.com/download-sample/nonalcoholic-fatty-liver-disease-market
Read Latest Blog: https://www.datamintelligence.com/blogs/top-10-process-automation-companies-worldwide
Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nonalcoholic Fatty Liver Disease (NAFLD) Market Booming Worldwide With Leading Key Players - Pfizer Inc., AstraZeneca, Novartis AG, Takeda Pharmaceutical Company Limited., Intercept Pharmaceuticals, Inc., F. Hoffmann-La Roche Ag, Merck & Co here
News-ID: 3580415 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Digital Oilfield Market to Reach 7.1% CAGR by 2032; North America Leads with 40% …
Market Overview
The Global Digital Oilfield Market is witnessing significant growth, with a CAGR of 7.1% during the forecast period. The market is driven by increasing adoption of advanced software and data analytics in oil and gas operations, enabling operators to enhance field productivity, reduce operational costs, and optimize decision-making processes.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/global-digital-oilfield-market?Juli
A digital oilfield leverages technology to simulate…
Hydropower Market to Reach US$ 348.2 Billion by 2030; Asia-Pacific Leads with 45 …
Market Overview
The global hydropower market reached US$ 244.1 billion in 2022 and is projected to reach US$ 348.2 billion by 2030, growing at a CAGR of 4.8% during 2024-2031. Hydropower continues to be a key renewable energy source worldwide, driven by innovations in turbine technology, dam design, and grid integration solutions. Although hydropower has a history of nearly 150 years, recent developments focus on improving efficiency, environmental sustainability, and integration…
China Renewable Energy Certificate Market to Reach US$ 4.2 Billion by 2032; Asia …
Market Overview
The China renewable energy certificate (REC) market reached US$ 1.2 billion in 2024 and is expected to reach US$ 4.2 billion by 2032, growing at a CAGR of 14.2% during the forecast period 2025-2032. China has been the world's largest and fastest-growing producer of renewable energy for over a decade, generating more than three times the renewable electricity of the United States. Its market share in RECs is significant…
Philippines Renewable Energy Certificate Market to Reach US$ 387.45 Million by 2 …
Market Overview
The Philippines Renewable Energy Certificate (REC) Market reached US$ 174.93 million in 2024 and is projected to reach US$ 387.45 million by 2032, growing at a CAGR of 9.8% during the forecast period 2025-2032. The growth is driven by the country's strong commitment to renewable energy development, supported by government policies and incentives promoting clean energy adoption. The Philippines possesses abundant renewable resources, including solar, wind, hydro, and geothermal…
More Releases for NAFLD
Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drugs Market to Reach 18 …
According to DataM Intelligence, the global Metabolic Dysfunction-Associated Steatohepatitis (MASH) drugs market reached US$ 180.1 million in 2024 and is expected to reach US$ 929.05 million by 2033, growing at a CAGR of 18.1% during 2025-2033, driven by increasing prevalence of metabolic dysfunction-associated steatohepatitis (formerly NASH), growing obesity and diabetes epidemics, strong pipeline advancements in FXR agonists, PPAR agonists, and GLP-1-based therapies, regulatory approvals for first-in-class treatments, and rising healthcare…
Nonalcoholic Fatty Liver Disease (NAFLD) Patient Pool Analysis Market to Reach U …
Pune, India - December 2025 - The global Nonalcoholic Fatty Liver Disease (NAFLD) Patient Pool Analysis Market, valued at USD 1.67 billion in 2024, is projected to reach USD 2.94 billion by 2034, growing at a 5.8% CAGR (2025-2034), according to Exactitude Consultancy. The rapid rise in obesity, type 2 diabetes, metabolic syndrome, and expanded liver health screening are increasing NAFLD patient identification worldwide.
Download Full PDF Sample Copy of Market…
Nonalcoholic Fatty Liver Disease (NAFLD) Patient Pool to Reach 1.7 Billion by 20 …
Nonalcoholic fatty liver disease (NAFLD) has emerged as one of the most pressing global health challenges of the 21st century. Characterized by the accumulation of fat in the liver not caused by alcohol consumption, NAFLD is closely associated with obesity, type 2 diabetes, and metabolic syndrome. In its severe form, nonalcoholic steatohepatitis (NASH), the disease can progress to cirrhosis, liver failure, or hepatocellular carcinoma, making it a major cause of…
Non-Alcoholic Fatty Liver Disease (NAFLD) Market Detailed Industry Report Analys …
Introduction
Non-Alcoholic Fatty Liver Disease (NAFLD) has emerged as one of the most pressing global health challenges of the 21st century. Closely linked to the growing prevalence of obesity, type 2 diabetes, and metabolic syndrome, NAFLD is now the most common liver disorder worldwide. It ranges from simple fat accumulation in the liver (steatosis) to the more severe inflammatory stage known as Non-Alcoholic Steatohepatitis (NASH), which can progress to fibrosis, cirrhosis,…
Non-Alcoholic Fatty Liver Disease (NAFLD) Market to Rise at 5.98% CAGR, Reaching …
BREAKING: The Non-Alcoholic Fatty Liver Disease NAFLD market is positioned to become the #1 game-changing force in the global Healthcare sector by 2035, creating unprecedented growth opportunities for manufacturers, technology providers, enterprise clients, solution developers and strategic investors worldwide.
This exclusive deep-dive report delivers comprehensive analysis of the rapidly evolving Non-Alcoholic Fatty Liver Disease NAFLD industry, uncovering breakthrough technological advancements, critical market milestones and transformative future projections. It explores the revolutionary…
Non Alcoholic Fatty Liver Disease (NAFLD) Market to Witness Growth by 2032, Esti …
DelveInsight's "Non Alcoholic Fatty Liver Disease (NAFLD) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Non Alcoholic Fatty Liver Disease (NAFLD), historical and forecasted epidemiology as well as the Non Alcoholic Fatty Liver Disease (NAFLD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Non Alcoholic Fatty Liver Disease (NAFLD) market report provides current treatment practices, emerging drugs,…
